, /PRNewswire/ -- Yatsen Group (NYSE: YSG), a world-class beauty innovation pioneer, recently released its 2025 Environmental, Social and Governance (ESG) Report, systematically disclosing the Company's annual practices and achievements across five key pillars: technological innovation, green development, scientific governance, talent development, and social impact.
Official Release of the “Yatsen Group Beauty Innovation White Paper”
Yatsen Group Talent Team "For Yatsen Group, sustainable development has never been an add-on outside our core business operations; it is an integral component of creating long-term value." stated David Huang, Founder, Chairman, and CEO of Yatsen Group.
Deepening Beauty R&D and Innovation
In 2025, Yatsen released China's first comprehensive Beauty Industry report, the "Yatsen Group Beauty Innovation White Paper" offering a thorough overview of its achievements in R&D investments, technical verification, and research collaboration between industry, academic and researchers.
R&D Capability: Annual R&D investment reached RMB 137 million (3.2% of total revenue), supported by 153 R&D personnel. The company accumulated 269 patent applications (240 authorized) and completed filings for two new cosmetic raw ingredients.
Brand Breakthroughs: Key innovations include Perfect Diary's 3rd-generation "Bio-film" Biotec™ technology and DR.WU's Nanoxinfuse™ delivery technology.
Academic Acclaim: Yatsen presented 11 research papers at the 35th IFSCC Congress—more than triple its 2024 total.
Accelerating Green and Low-Carbon Transformation
Alongside R&D, green transformation is another crucial path in Yatsen's commitment to long-term value, rooted in the belief that true growth must coexist with environmental stewardship.
Sustainable Packaging: Yatsen contributed to the group standard "Sustainable Packaging Guidelines-Cosmetics". Brands like Galénic and EVE LOM led implementations.
100% of product folding cartons utilize FSC-certified paper and soy-based inks; refillable designs cut total packaging volume. Some Galénic products sold in China use 100% biodegradable bio-based paper-plastic materials to replace conventional plastics for product boxes. EVE LOM achieved 100% recyclable or recycled outer packaging across all lines and 100% plant-based biodegradable single-use capsule packaging. DR.WU and Perfect Diary also advanced lightweight packaging initiatives to cut resource consumption. Climate Action: Yatsen advanced its carbon neutrality goals and milestone reduction pathways across risk assessment, operational efficiency, supply chain alignment, and product carbon footprint management.
In 2025, greenhouse gas emissions from direct operations fell by 35.74% year-over-year. The core manufacturing hub, Yatsen Biotechnology, expanded photovoltaic installations and optimized its energy mix—achieving a 41% renewable energy utilization rate and 100% product carbon footprint assessment coverage. This solid progress reflects Yatsen's understanding of "long-term value"—not the pursuit of immediate results, but making green transformation part of sustainable growth.
Solidifying Governance as a Growth Foundation
In response to the integration of AI and digital technologies, Yatsen reinforced its board-led ESG governance architecture, clearly defining accountability boundaries and data security protocols for emerging tech applications. Business ethics, risk management, information security, and regulatory compliance are integrated into all operational decisions.
Key compliance and governance highlights in 2025 include:
100% Ethics Training: Business ethics training achieved 100% employee coverage.
Zero Violation Incidents: Zero incidents or lawsuits involving corruption, bribery, discrimination, harassment, privacy breaches, money laundering, or insider trading were reported.
Level III Security Certification: The group's core systems earned Level III Certification in Cybersecurity Graded Protection Assessment from the Guangzhou Public Security Bureau.
Strengthened Privacy Governance: A Data Protection Officer was appointed to oversee privacy inquiries, supervise personal information processing, and lead regular Privacy Impact Assessments. Consequently, Yatsen experienced zero information security incidents and received zero personal-information-protection complaints in 2025.
Empowering Talent: Letting the Capable Thrive
Effective governance relies on talent and organizational strength. For Yatsen, talent is not only the foundation of the company's development but also a key force driving innovation and executing long-term strategy.
Diversity & Representation: In China, women comprise 77.0% of the total workforce, 60.7% of senior management, 72% of revenue-generating management roles, and 63% of STEM-related positions.
Employee Empowerment: 11.3% of employees participate in the employee stock ownership plan; total employee training reached 12,575 hours.
Occupational Safety: Achieved zero work-related fatalities and zero lost workdays due to occupational injuries in 2025.
From growth opportunities to career security, Yatsen continuously refines its employee support system, giving every employee room to excel and letting the capable thrive.
Fostering Social Impact Through Philanthropy
Yatsen believes long-term value extends beyond commercial returns to addressing social needs and creating positive community outcomes.
Creating a Beautiful Life Program: Over more than four years, the initiative conducted 12 sessions across Sichuan, Guangdong, and Guizhou, empowering a cumulative 482 female trainees.
Green Love Computer Room Program: Launched in 2022, the program has donated nearly 450 sets of computers and projectors across six cities (including Shaoguan, Qingyuan, and Zhaoqing), establishing eight computer labs supported by employee volunteers.
Charitable Giving: Total public welfare donations reached RMB 1.5 million in 2025.
From R&D investments and low-carbon transitions to corporate governance, talent development, and philanthropy, Yatsen Group demonstrates that having a long-term value is not merely a slogan, but a guiding principle integrated into everyday business decisions.
Moving forward, Yatsen will remain user-centric and technology-driven—collaborating with consumers, employees, partners, and society to advance toward its vision of becoming a "World-Class Beauty Innovation Pioneer."
About Yatsen Group
Yatsen Holding Limited (NYSE: YSG) is a leading China-based beauty group with the vision of becoming a world-class pioneer in beauty innovation. Founded in 2016, the Company has launched and acquired numerous color cosmetics and skincare brands including Perfect Diary, Little Ondine, Pink Bear, Galénic, DR.WU (its mainland China business), and Eve Lom. Our brands are strategically positioned to capture a wide spectrum of consumer demographics and price points, ranging from the mass market to the prestige and clinical segments. Yatsen thrives on the synergy of brand equity, product strength and operational agility, anchored by a strong commitment to R&D and consumer insights.
Yatsen NYSE: YSG reported second-quarter 2026 revenue growth of 5.1% as continued strength in its skincare portfolio offset a sharp decline in color cosmetics sales, while higher inventory provisions and increased marketing spending widened the company’s losses.
Total net revenue rose to RMB1.14 billion from RMB1.09 billion a year earlier. Founder, Chairman and CEO Jinfeng Huang said the result reflected continued progress in the company’s strategic transformation despite a challenging competitive environment for China’s beauty industry.
Get Yatsen alerts:
“While overall growth was more moderate than our prior expectations, our skincare portfolio delivered exceptional performance,” Huang said, adding that the company’s skincare brands have become a core driver of growth.
Skincare Becomes the Dominant Revenue Driver Revenue from Yatsen’s skincare brands increased 40.4% year over year during the quarter and accounted for 71.5% of total net revenue. That performance was partly offset by a 35.8% decline in revenue from color cosmetics brands, which management attributed to deliberate brand portfolio optimization and SKU rationalization.
Huang said the shift in the revenue mix toward skincare represents a move toward “higher quality, more sustainable growth.” The company continued to invest in research and development, with R&D expense representing 3.3% of total revenue in the quarter, broadly consistent with the prior-year period.
During the quarter, Yatsen expanded product offerings across its skincare portfolio. Galénic launched an Active Eye Cream under its Couture Révélation Cellulaire line; DR.WU introduced three essence masks targeting oil control, hydration and soothing care; and Eve Lom expanded its second-generation Vital Dew range with a hydration cream and skin infusion serum.
Management also cited brand-building activities, including a DR.WU livestreaming event with cctv.com that attracted a cumulative audience of 178 million viewers. Galénic held a summer campaign pop-up event on Wuzhizhou Island in Sanya, while Eve Lom participated in the British Beauty Festival.
Margins and Losses Widen Gross profit declined 0.8% year over year to RMB843.8 million, while gross margin fell to 73.9% from 78.3%. Huang and CFO Donghao Yang said the decline was primarily related to higher inventory provisions in the color cosmetics business amid portfolio optimization and SKU reductions.
Huang said that excluding the impact of the one-time inventory provisions, underlying gross margin would have been roughly stable from a year earlier.
Total operating expenses increased 7.7% to RMB975.7 million, or 85.4% of revenue, compared with 83.4% a year earlier. Selling and marketing expense climbed to RMB807.6 million, representing 70.7% of revenue, from RMB722.4 million, or 66.5% of revenue, in the prior-year period.
Yang said the increase reflected investments to build consumer awareness and long-term brand equity for the company’s core skincare brands, along with higher traffic acquisition costs on Douyin as Yatsen pursued growth opportunities on the platform.
Fulfillment expenses declined to RMB56.1 million from RMB63.3 million, which Yang attributed to improved logistics efficiency. General and administrative expenses fell to RMB74.8 million from RMB84.1 million, primarily due to lower share-based compensation expenses.
Operating loss: RMB131.9 million, compared with RMB55.5 million a year earlier. Non-GAAP operating loss: RMB112.1 million, compared with RMB20.4 million a year earlier. Net loss: RMB90.8 million, compared with RMB19.5 million a year earlier. Non-GAAP net loss: RMB99.4 million, compared with non-GAAP net income of RMB11.5 million a year earlier. Net cash used in operating activities was RMB78 million, compared with RMB77.7 million of cash generated from operations in the prior-year quarter. As of June 30, Yatsen had RMB1.06 billion in cash, restricted cash and short-term investments, compared with RMB1.05 billion at the end of 2025.
Channel Diversification and Marketing Efficiency During the question-and-answer session, newly appointed Co-Chief Financial Officer Li Wang said expanding distribution channels will be important to the next stage of growth for Yatsen’s skincare brands.
Wang said the company plans to supplement its core Tmall and Douyin channels with online business-to-business platforms including JD, Vipshop and TBD, as well as offline distribution, duty-free and professional channels. She said such channels generally have lower traffic costs and can support a healthier profitability profile.
DR.WU has already demonstrated that a higher business-to-business sales mix can support both growth and profitability, Wang said, adding that Yatsen intends to selectively apply that model to other skincare brands. The company is also pursuing differentiated formats, including Galénic boutique stores in premium department stores and shopping malls, and DR.WU distribution through over-the-counter drugstore channels.
To address rising online traffic costs, Wang said Yatsen is directing more resources toward higher-growth and higher-return skincare brands, expanding professional and business-to-business channels, and improving content creation, customer relationship management retention and budget allocation. The company is also using AI agents as part of efforts to strengthen financial discipline and marketing efficiency.
“The goal is not to cut investment blindly,” Wang said. “Our goal is to support strong skincare growth with better efficiency and stronger profitability over time.”
Third-Quarter Outlook and Finance Leadership Update For the third quarter of 2026, Yatsen expects total net revenue of between RMB898.6 million and RMB998.4 million, representing a year-over-year decline of approximately 0% to 10%.
Huang also announced that Wang Li was appointed Co-Chief Financial Officer effective immediately. Wang has more than 15 years of experience in the consumer and beauty industries and most recently served as CFO of Proya Cosmetics, according to Huang. She will work alongside Yang to support cost-structure optimization, resource allocation and the company’s pursuit of sustainable profitable growth.
About Yatsen (NYSE:YSG)Yatsen Holding Limited NYSE: YSG is a Shanghai-based beauty and personal care company founded in 2016. The firm operates as a digital-first cosmetics provider, designing, developing and marketing its own brands to a primarily Chinese consumer base. Since its inception, Yatsen has focused on leveraging data analytics and social media engagement to drive product innovation and brand awareness.
The company's core portfolio includes Perfect Diary, a color-cosmetics brand offering lipsticks, eyeshadows, foundations and related accessories; Little Ondine, which specializes in nail lacquers and nail care products; Winona, a sensitive-skin skincare line; and Abby's Choice, which features targeted skincare treatments.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Should You Invest $1,000 in Yatsen Right Now?Before you consider Yatsen, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Yatsen wasn't on the list.
While Yatsen currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.
This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.
Yatsen Holding Limited (YSG) Q2 2026 Earnings Call September 2, 2026 7:30 AM EDT
Company Participants
Irene Lyu - Head of Strategic Investments & Capital Markets
Jinfeng Huang - Founder, CEO & Chairman of the Board of Directors
Donghao Yang - CFO & Director
Conference Call Participants
Manqi Huang - China International Capital Corporation Limited, Research Division
Presentation
Operator
Ladies and gentlemen, good day and welcome to the Yatsen's second quarter 2026 earnings conference call. Today's conference is being recorded.
At this time, I would like to turn the conference over to Irene Lyu, Vice President, Head of Strategic Investment and Capital Markets. Please go ahead.
Irene Lyu
Head of Strategic Investments & Capital Markets
Thank you, operator. Please note, the discussion today will contain forward-looking statements relating to the company's future performance and are intended to qualify for the safe harbor from liability as established by the U.S. Private Securities Litigation Reform Act. Such statements are not guarantees of future performance and are subject to certain risks and uncertainties, assumptions and other factors. Some of these risks are beyond the company's control and could cause actual results to differ materially from those mentioned in today's press release and this discussion.
A general discussion of the risk factors that could affect Yatsen's business and financial results is included in certain filings of the company with the Securities and Exchange Commission. The company does not undertake any obligation to update this forward-looking information except as required by law. During today's call, management will also discuss certain non-GAAP financial measures for comparison purposes only. Please see the earnings release issued earlier today for a definition of non-GAAP financial measures and a reconciliation of GAAP to non-GAAP financial results.
Joining us today on the call from Yatsen's senior management are Mr. Jinfeng Huang, our Founder, Chairman, CEO, and
Conference Call to Be Held at 7:30 A.M. U.S. Eastern Time on September 2, 2026
, /PRNewswire/ -- Yatsen Holding Limited ("Yatsen" or the "Company") (NYSE: YSG), a leading China-based beauty group, today announced its unaudited financial results for the quarter ended June 30, 2026.
Second Quarter 2026 Highlights
Total net revenues for the second quarter of 2026 increased by 5.1% to RMB1.14 billion (US$168.3 million) from RMB1.09 billion for the prior year period. Total net revenues from Skincare Brands[1] for the second quarter of 2026 increased by 40.4% to RMB816.1 million (US$120.3 million) from RMB581.3 million for the prior year period. As a percentage of total net revenues, total net revenues from Skincare Brands for the second quarter of 2026 were 71.5%, as compared with 53.5% for the prior year period. Gross margin for the second quarter of 2026 decreased to 73.9% from 78.3% for the prior year period. Net loss for the second quarter of 2026 was RMB90.8 million (US$13.4 million), as compared with RMB19.5 million for the prior year period. Non-GAAP net loss[2] for the second quarter of 2026 was RMB99.4 million (US$14.7 million), as compared with non-GAAP net income of RMB11.5 million for the prior year period. Mr. Jinfeng Huang, Founder, Chairman and Chief Executive Officer of Yatsen, stated, "China's beauty market demonstrated broad resilience in the second quarter, with market growth showing slight improvement but remaining challenged as competition across the industry intensified. Against this backdrop, our business continued to navigate a critical phase of strategic transformation. As we further optimized our brand portfolio and distribution channels, our skincare portfolio maintained its strong growth momentum — now representing over 70% of total revenues — led by the robust performance of our clinical and premium skincare brands, including Galénic, DR.WU and Eve Lom. In contrast, our color cosmetics segment faced structural headwinds amid heightened competition. As a result, we are taking decisive actions to streamline our color cosmetics portfolio and refocus resources on our high-growth skincare brands. Looking ahead, we aim to further optimize our product portfolio and channel execution, while maintaining investments in R&D to strengthen our innovation pipeline for sustainable long-term growth."
Mr. Donghao Yang, Director and Chief Financial Officer of Yatsen, commented, "We delivered modest top-line growth in the second quarter of 2026, with net revenues increasing 5.1% year over year. This performance was primarily driven by a 40.4% year-over-year growth in our skincare segment, which more than offset revenue pressure in our color cosmetics business. Looking ahead, amid dynamic market conditions, we remain committed to maintaining operational discipline, with a continued focus on improving marketing spend efficiency and progressively optimizing our operating cost structure."
Second Quarter 2026 Financial Results
Net Revenues
Total net revenues for the second quarter of 2026 increased by 5.1% to RMB1.14 billion (US$168.3 million) from RMB1.09 billion for the prior year period. The increase was primarily driven by a 40.4% year-over-year increase in net revenues from Skincare Brands, which more than offset a 35.8% year-over-year decrease in net revenues from Color Cosmetics Brands.[3]
Gross Profit and Gross Margin
Gross profit for the second quarter of 2026 decreased by 0.8% to RMB843.8 million (US$124.4 million) from RMB850.4 million for the prior year period. Gross margin for the second quarter of 2026 decreased to 73.9% from 78.3% for the prior year period, primarily due to higher inventory provisions in the color cosmetics business associated with the Company's proactive brand portfolio optimization and SKU rationalization.
Operating Expenses
Total operating expenses for the second quarter of 2026 increased by 7.7% to RMB975.7 million (US$143.8 million) from RMB905.9 million for the prior year period. As a percentage of total net revenues, total operating expenses for the second quarter of 2026 were 85.4%, as compared with 83.4% for the prior year period.
Fulfillment Expenses. Fulfillment expenses for the second quarter of 2026 were RMB56.1 million (US$8.3 million), as compared with RMB63.3 million for the prior year period. As a percentage of total net revenues, fulfillment expenses for the second quarter of 2026 decreased to 4.9% from 5.8% for the prior year period. The decrease was primarily attributable to further improvements in logistics efficiency. Selling and Marketing Expenses. Selling and marketing expenses for the second quarter of 2026 were RMB807.6 million (US$119.0 million), as compared with RMB722.4 million for the prior year period. As a percentage of total net revenues, selling and marketing expenses for the second quarter of 2026 increased to 70.7% from 66.5% for the prior year period. The increase was primarily driven by strategic investments in broadening consumer awareness and building long-term brand equity of our core skincare brands, coupled with higher traffic acquisition costs on the Douyin platform as the Company capitalized on the channel's strong growth momentum. General and Administrative Expenses. General and administrative expenses for the second quarter of 2026 were RMB74.8 million (US$11.0 million), as compared with RMB84.1 million for the prior year period. As a percentage of total net revenues, general and administrative expenses for the second quarter of 2026 were 6.6% as compared with 7.7% for the prior year period. The decrease was primarily driven by lower share-based compensation expenses. Research and Development Expenses. Research and development expenses for the second quarter of 2026 were RMB37.3 million (US$5.5 million), as compared with RMB36.1 million for the prior year period. As a percentage of total net revenues, research and development expenses for the second quarter of 2026 were 3.3%, consistent with the prior year period. Loss / Income from Operations
Loss from operations for the second quarter of 2026 was RMB131.9 million (US$19.4 million), as compared with RMB55.5 million for the prior year period. Operating loss margin was 11.5%, as compared with 5.1% for the prior year period.
Non-GAAP loss from operations[4] for the second quarter of 2026 was RMB112.1 million (US$16.5 million), as compared with RMB20.4 million for the prior year period. Non-GAAP operating loss margin[5] was 9.8%, as compared with 1.9% for the prior year period.
Net Loss / Income
Net loss for the second quarter of 2026 was RMB90.8 million (US$13.4 million), as compared with RMB19.5 million for the prior year period. Net loss margin was 8.0%, as compared with 1.8% for the prior year period. Net loss attributable to Yatsen's ordinary shareholders per diluted ADS[6] for the second quarter of 2026 was RMB0.97 (US$0.14), as compared with RMB0.19 for the prior year period.
Non-GAAP net loss for the second quarter of 2026 was RMB99.4 million (US$14.7 million), as compared with non-GAAP net income of RMB11.5 million for the prior year period. Non-GAAP net loss margin was 8.7%, as compared with non-GAAP net income margin of 1.1% for the prior year period. Non-GAAP net loss attributable to Yatsen's ordinary shareholders per diluted ADS[7] for the second quarter of 2026 was RMB1.06 (US$0.16), as compared with non-GAAP net income attributable to Yatsen's ordinary shareholders per diluted ADS of RMB0.13 for the prior year period.
Balance Sheet and Cash Flow
As of June 30, 2026, the Company had cash, restricted cash and short-term investments of RMB1.06 billion (US$155.6 million), as compared with RMB1.05 billion as of December 31, 2025.
Net cash used in operating activities for the second quarter of 2026 was RMB78.0 million (US$11.5 million), as compared with net cash generated from operating activities of RMB77.7 million for the prior year period.
Appointment of Co-Chief Financial Officer
The Company is pleased to announce the appointment of Ms. Li Wang as Co-Chief Financial Officer, effective September 2, 2026. Ms. Wang brings over 15 years of experience in the consumer industry, having previously served as Chief Financial Officer at Proya Cosmetics Co., Ltd. and holding multiple professional accounting qualifications, including CMA, HKICPA and FIPA.
Ms. Wang will partner with Mr. Donghao Yang, the Company's Director and Chief Financial Officer, to ensure a seamless transition and provide continuity in the Company's financial leadership, and she is expected to succeed Mr. Yang as Chief Financial Officer after the release of the 2026 annual report on Form 20-F. The appointment reflects the Company's commitment to building a world-class leadership team and will further support the Company's ongoing strategic transformation and its focus on sustainable, profitable growth.
Business Outlook
For the third quarter of 2026, the Company expects its total net revenues to be between RMB898.6 million and RMB998.4 million, representing a year-over-year decrease of approximately 0% to 10%. These forecasts reflect the Company's current and preliminary views on the market and operational conditions, which are subject to change.
Exchange Rate
This announcement contains translations of certain Renminbi ("RMB") amounts into U.S. dollars ("US$") at specified rates solely for the convenience of the reader. Unless otherwise noted, all translations from RMB to US$ were made at a rate of RMB6.7851 to US$1.00, the exchange rate in effect as of June 30, 2026, as set forth in the H.10 statistical release of The Board of Governors of the Federal Reserve System. The Company makes no representation that any RMB or US$ amounts could have been, or could be, converted into US$ or RMB, as the case may be, at any particular rate, or at all.
[1] Include net revenues from Galénic, DR.WU (its mainland China business), Eve Lom and other skincare brands of the Company.
[2] Non-GAAP net income (loss) is a non-GAAP financial measure. Non-GAAP net income (loss) is defined as net income (loss) excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions, (iii) revaluation of investments on the share of equity method investments, (iv) impairment of goodwill, (v) impairment of investments and (vi) tax effects on non-GAAP adjustments.
[3] Include Perfect Diary, Little Ondine, Pink Bear and other color cosmetics brands of the Company.
[4] Non-GAAP income (loss) from operations is a non-GAAP financial measure. Non-GAAP income (loss) from operations is defined as income (loss) from operations excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions and (iii) impairment of goodwill.
[5] Non-GAAP operating income (loss) margin is a non-GAAP financial measure, which is defined as non-GAAP net income (loss) from operations as a percentage of total net revenues.
[6] ADS refers to American depositary shares, each of which represents twenty Class A ordinary shares.
[7] Non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS is a non-GAAP financial measure. Non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS is defined as non-GAAP net income (loss) attributable to ordinary shareholders divided by the weighted average number of diluted ADS outstanding for computing diluted earnings per ADS. Non-GAAP net income (loss) attributable to ordinary shareholders is defined as net income (loss) attributable to ordinary shareholders excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions, (iii) revaluation of investments on the share of equity method investments, (iv) impairment of goodwill, (v) impairment of investments, (vi) tax effects on non-GAAP adjustments and (vii) accretion to redeemable non-controlling interests.
Conference Call Information
The Company's management will hold a conference call on Wednesday, September 2, 2026, at 7:30 A.M. U.S. Eastern Time or 7:30 P.M. Beijing Time to discuss its financial results and operating performance for the second quarter of 2026.
United States (toll free):
+1-888-346-8982
International:
+1-412-902-4272
Mainland China (toll free):
400-120-1203
Hong Kong, SAR (toll free):
800-905-945
Hong Kong, SAR:
+852-3018-4992
The replay will be accessible through Wednesday, September 9, 2026 by dialing the following numbers:
United States:
+1-855-669-9658
International:
+1-412-317-0088
Replay Access Code:
3486688
A live and archived webcast of the conference call will also be available on the Company's investor relations website at http://ir.yatsenglobal.com.
About Yatsen Holding Limited
Yatsen Holding Limited (NYSE: YSG) is a leading China-based beauty group with the vision of becoming a world-class pioneer in beauty innovation. Founded in 2016, the Company has launched and acquired numerous color cosmetics and skincare brands including Perfect Diary, Little Ondine, Pink Bear, Galénic, DR.WU (its mainland China business), and Eve Lom. Our brands are strategically positioned to capture a wide spectrum of consumer demographics and price points, ranging from the mass market to the prestige and clinical segments. Yatsen thrives on the synergy of brand equity, product strength and operational agility, anchored by a strong commitment to R&D and consumer insights.
For more information, please visit http://ir.yatsenglobal.com.
Use of Non-GAAP Financial Measures
The Company uses non-GAAP income (loss) from operations, non-GAAP operating income (loss) margin, non-GAAP net income (loss), non-GAAP net income (loss) margin, non-GAAP net income (loss) attributable to ordinary shareholders and non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS, each a non-GAAP financial measure, in reviewing and assessing its operating performance. The presentation of these non-GAAP financial measures is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with U.S. GAAP. The Company presents these non-GAAP financial measures because they are used by the management to evaluate operating performance and formulate business plans. Non-GAAP financial measures help identify underlying trends in its business, provide further information about its results of operations, and enhance the overall understanding of its past performance and future prospects. The Company defines non-GAAP income (loss) from operations as income (loss) from operations excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions and (iii) impairment of goodwill. Non-GAAP operating income (loss) margin is non-GAAP income (loss) from operations as a percentage of total net revenues. The Company defines non-GAAP net income (loss) as net income (loss) excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions, (iii) revaluation of investments on the share of equity method investments, (iv) impairment of goodwill, (v) impairment of investments and (vi) tax effects on non-GAAP adjustments. Non-GAAP net income (loss) margin is non-GAAP net income (loss) as a percentage of total net revenues. The Company defines non-GAAP net income (loss) attributable to ordinary shareholders as net income (loss) attributable to ordinary shareholders excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions, (iii) revaluation of investments on the share of equity method investments, (iv) impairment of goodwill, (v) impairment of investments, (vi) tax effects on non-GAAP adjustments and (vii) accretion to redeemable non-controlling interests. Non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS is computed using non-GAAP net income (loss) attributable to ordinary shareholders divided by weighted average number of diluted ADS outstanding for computing diluted earnings per ADS.
However, the non-GAAP financial measures have limitations as analytical tools as the non-GAAP financial measures are not presented in accordance with U.S. GAAP and may differ from the non-GAAP information used by other companies, including peer companies, and therefore their comparability may be limited. The Company compensates for these limitations by reconciling the non-GAAP financial measures to the nearest U.S. GAAP performance measure, all of which should be considered when evaluating performance. The Company encourages investors and others to review its financial information in its entirety and not rely on a single financial measure. Reconciliations of Yatsen's non-GAAP financial measures to the most comparable U.S. GAAP measure are included at the end of this press release.
Safe Harbor Statement
This announcement contains statements that may constitute "forward-looking" statements which are made pursuant to the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "aims," "future," "intends," "plans," "believes," "estimates," "likely to," and similar statements. The Company may also make written or oral forward-looking statements in its periodic reports to the Securities and Exchange Commission ("SEC"), in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about the Company's beliefs, plans, outlook and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the Company's growth strategies; its future business development, results of operations and financial condition; its ability to continue to roll out popular products and maintain popularity of existing products; its ability to anticipate and respond to changes in industry trends and consumer preferences and behavior in a timely manner; its ability to attract and retain new customers and to increase revenues generated from repeat customers; its expectations regarding demand for and market acceptance of its products and services; its ability to integrate newly-acquired businesses and brands; trends and competition in and relevant government policies and regulations relating to China's beauty market; changes in its revenues and certain cost or expense items; and general economic conditions globally and in China. Further information regarding these and other risks is included in the Company's filings with the SEC. All information provided in this press release is as of the date of this press release, and the Company does not undertake any obligation to update any forward-looking statement, except as required under applicable law.
(All amounts in thousands, except for share, per share data or otherwise noted)
December 31,
June 30,
June 30,
2025
2026
2026
RMB'000
RMB'000
USD'000
Assets
Current assets
Cash and cash equivalents
765,379
710,286
104,683
Restricted cash
42,117
4,667
688
Short-term investments
246,008
340,545
50,190
Accounts receivable, net
220,870
216,722
31,941
Inventories, net
508,730
554,572
81,734
Prepayments and other current assets
450,970
411,660
60,671
Amounts due from related parties
114
68
10
Total current assets
2,234,188
2,238,520
329,917
Non-current assets
Investments
653,560
765,582
112,833
Property and equipment, net
77,014
66,072
9,738
Goodwill, net
155,029
155,029
22,848
Intangible assets, net
537,509
491,158
72,388
Deferred tax assets
1,435
686
101
Right-of-use assets, net
173,915
181,682
26,777
Other non-current assets
14,332
25,940
3,823
Total non-current assets
1,612,794
1,686,149
248,508
Total assets
3,846,982
3,924,669
578,425
Liabilities, redeemable non-controlling interests and shareholders'
equity
Current liabilities
Accounts and notes payable
149,371
174,451
25,711
Advances from customers
28,821
32,070
4,727
Accrued expenses and other liabilities
348,700
304,369
44,858
Amounts due to related parties
21,262
19,577
2,885
Income tax payables
13,690
13,779
2,031
Lease liabilities due within one year
53,435
61,256
9,028
Total current liabilities
615,279
605,502
89,240
Non-current liabilities
Convertible notes
-
408,654
60,228
Deferred tax liabilities
107,906
112,343
16,557
Lease liabilities
123,157
127,790
18,834
Total non-current liabilities
231,063
648,787
95,619
Total liabilities
846,342
1,254,289
184,859
Redeemable non-controlling interests
1,337
1,337
197
Shareholders' equity
Ordinary Shares (US$0.00001 par value; 10,000,000,000 ordinary
shares authorized, comprising of 6,000,000,000 Class A ordinary
shares, 960,852,606 Class B ordinary shares and 3,039,147,394
shares each of such classes to be designated as of December 31,
2025 and June 30, 2026; 2,096,600,883 Class A shares and
600,572,880 Class B ordinary shares issued as of December 31,
2025 and June 30, 2026; 1,276,663,163 Class A ordinary shares
and 600,572,880 Class B ordinary shares outstanding as of
December 31, 2025, 1,275,438,103 Class A ordinary shares and
600,572,880 Class B ordinary shares outstanding as of June 30,
2026)
173
173
25
Treasury shares
(1,250,678)
(1,275,611)
(188,002)
Additional paid-in capital
12,296,367
12,178,055
1,794,823
Statutory reserve
31,527
31,527
4,647
Accumulated deficit
(8,141,545)
(8,292,887)
(1,222,220)
Accumulated other comprehensive income
74,760
27,786
4,096
Total Yatsen Holding Limited shareholders' equity
3,010,604
2,669,043
393,369
Non-controlling interests
(11,301)
-
-
Total shareholders' equity
2,999,303
2,669,043
393,369
Total liabilities, redeemable non-controlling interests and
shareholders' equity
3,846,982
3,924,669
578,425
YATSEN HOLDING LIMITED
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(All amounts in thousands, except for share, per share data or otherwise noted)
For the Three Months Ended June 30,
For the Six Months Ended June 30,
2025
2026
2026
2025
2026
2026
RMB'000
RMB'000
USD'000
RMB'000
RMB'000
USD'000
Total net revenues
1,086,732
1,142,180
168,337
1,920,265
2,163,166
318,811
Total cost of revenues
(236,335)
(298,361)
(43,973)
(410,741)
(500,158)
(73,714)
Gross profit
850,397
843,819
124,364
1,509,524
1,663,008
245,097
Operating expenses:
Fulfilment expenses
(63,288)
(56,089)
(8,266)
(115,131)
(117,227)
(17,277)
Selling and marketing expenses
(722,405)
(807,559)
(119,019)
(1,276,220)
(1,544,795)
(227,675)
General and administrative expenses
(84,072)
(74,815)
(11,026)
(148,955)
(155,141)
(22,865)
Research and development expenses
(36,116)
(37,250)
(5,490)
(58,753)
(76,690)
(11,303)
Total operating expenses
(905,881)
(975,713)
(143,801)
(1,599,059)
(1,893,853)
(279,120)
Loss from operations
(55,484)
(131,894)
(19,437)
(89,535)
(230,845)
(34,023)
Financial income
11,467
3,883
572
22,073
14,624
2,155
Interest expenses
-
(743)
(110)
-
(743)
(110)
Foreign currency exchange gain (loss)
5,507
402
59
16,171
(2,796)
(412)
Income from equity method investments, net
877
38,204
5,631
3,382
50,593
7,456
Other income, net
17,395
7,158
1,055
21,637
25,624
3,777
Loss before income tax expenses
(20,238)
(82,990)
(12,230)
(26,272)
(143,543)
(21,157)
Income tax benefits (expenses)
763
(7,838)
(1,155)
1,196
(9,213)
(1,358)
Net loss
(19,475)
(90,828)
(13,385)
(25,076)
(152,756)
(22,515)
Net loss attributable to non-controlling interests and redeemable non-
controlling interests
1,807
-
-
2,105
1,414
208
Net loss attributable to Yatsen's shareholders
(17,668)
(90,828)
(13,385)
(22,971)
(151,342)
(22,307)
Shares used in calculating loss per share (1):
Weighted average number of Class A and Class B ordinary shares:
Basic
1,854,988,850
1,874,649,633
1,874,649,633
1,846,275,864
1,875,769,426
1,875,769,426
Diluted
1,854,988,850
1,874,649,633
1,874,649,633
1,846,275,864
1,875,769,426
1,875,769,426
Net loss per Class A and Class B ordinary share
Basic
(0.01)
(0.05)
(0.01)
(0.01)
(0.08)
(0.01)
Diluted
(0.01)
(0.05)
(0.01)
(0.01)
(0.08)
(0.01)
Net loss per ADS (20 ordinary shares equal to 1 ADS)
Basic
(0.19)
(0.97)
(0.14)
(0.25)
(1.61)
(0.24)
Diluted
(0.19)
(0.97)
(0.14)
(0.25)
(1.61)
(0.24)
For the Three Months Ended June 30,
For the Six Months Ended June 30,
2025
2026
2026
2025
2026
2026
Share-based compensation expenses are included in the
operating expenses as follows:
RMB'000
RMB'000
USD'000
RMB'000
RMB'000
USD'000
Fulfilment expenses (income)
93
(46)
(7)
191
203
30
Selling and marketing expenses
1,795
2,396
353
2,552
2,544
375
General and administrative expenses
20,638
6,132
904
28,369
8,135
1,199
Research and development expenses
1,429
737
109
1,469
1,896
279
Total
23,955
9,219
1,359
32,581
12,778
1,883
(1) Authorized share capital is re-classified and re-designated into Class A ordinary shares and Class B ordinary shares, with each Class A ordinary share being entitled to one vote and each Class B
ordinary share being entitled to twenty votes on all matters that are subject to shareholder vote.
YATSEN HOLDING LIMITED
UNAUDITED RECONCILIATIONS OF GAAP AND NON-GAAP RESULTS
(All amounts in thousands, except for share, per share data or otherwise noted)
For the Three Months Ended June 30,
For the Six Months Ended June 30,
2025
2026
2026
2025
2026
2026
RMB'000
RMB'000
USD'000
RMB'000
RMB'000
USD'000
Loss from operations
(55,484)
(131,894)
(19,437)
(89,535)
(230,845)
(34,023)
Share-based compensation expenses
23,955
9,219
1,359
32,581
12,778
1,883
Amortization of intangible assets resulting from assets and business
acquisitions
11,147
10,624
1,566
21,708
21,383
3,151
Non-GAAP loss from operations
(20,382)
(112,051)
(16,512)
(35,246)
(196,684)
(28,989)
Net loss
(19,475)
(90,828)
(13,385)
(25,076)
(152,756)
(22,515)
Share-based compensation expenses
23,955
9,219
1,359
32,581
12,778
1,883
Amortization of intangible assets resulting from assets and business
acquisitions
11,147
10,624
1,566
21,708
21,383
3,151
Revaluation of investments on the share of equity method
investments
(3,141)
(35,578)
(5,244)
(9,151)
(46,047)
(6,786)
Tax effects on non-GAAP adjustments
(991)
7,122
1,050
(1,424)
7,951
1,172
Non-GAAP net income (loss)
11,495
(99,441)
(14,654)
18,638
(156,691)
(23,095)
Net loss attributable to Yatsen's shareholders
(17,668)
(90,828)
(13,385)
(22,971)
(151,342)
(22,307)
Share-based compensation expenses
23,955
9,219
1,359
32,581
12,778
1,883
Amortization of intangible assets resulting from assets and business
acquisitions
10,743
10,624
1,566
20,922
21,097
3,109
Revaluation of investments on the share of equity method
investments
(3,141)
(35,578)
(5,244)
(9,151)
(46,047)
(6,786)
Tax effects on non-GAAP adjustments
(963)
7,122
1,050
(1,368)
7,951
1,172
Non-GAAP net income (loss) attributable to Yatsen's
shareholders
12,926
(99,441)
(14,654)
20,013
(155,563)
(22,929)
Shares used in calculating loss per share:
Weighted average number of Class A and Class B ordinary shares:
Basic
1,854,988,850
1,874,649,633
1,874,649,633
1,846,275,864
1,875,769,426
1,875,769,426
Diluted
1,998,882,473
1,874,649,633
1,874,649,633
1,980,640,851
1,875,769,426
1,875,769,426
Non-GAAP net income (loss) attributable to ordinary
shareholders per Class A and Class B ordinary share
Basic
0.01
(0.05)
(0.01)
0.01
(0.08)
(0.01)
Diluted
0.01
(0.05)
(0.01)
0.01
(0.08)
(0.01)
Non-GAAP net income (loss) attributable to ordinary
shareholders per ADS (20 ordinary shares equal to 1 ADS)
, /PRNewswire/ -- Yatsen Holding Limited ("Yatsen" or the "Company") (NYSE: YSG), a leading China-based beauty group, today announced that it will release its unaudited financial results for the second quarter of 2026, on Wednesday, September 2, 2026, before the open of the U.S. markets.
The Company's management will hold a conference call on Wednesday, September 2, 2026 at 7:30 A.M. U.S. Eastern Time (7:30 P.M. Beijing/Hong Kong Time) to discuss the financial results. Listeners may access the call by dialing the following numbers:
United States (toll free):
+1-888-346-8982
International:
+1-412-902-4272
Mainland China (toll free):
400-120-1203
Hong Kong (toll free):
800-905-945
Hong Kong:
+852-3018-4992
A live and archived webcast of the conference call will be available on the Company's investor relations website at http://ir.yatsenglobal.com.
A replay of the conference call will be accessible by phone one hour after the conclusion of the live call at the following numbers, until September 9, 2026:
United States:
+1-855-669-9658
International:
+1-412-317-0088
Replay Access Code:
3486688
About Yatsen Holding Limited
Yatsen Holding Limited (NYSE: YSG) is a leading China-based beauty group with the vision of becoming a world-class pioneer in beauty innovation. Founded in 2016, the Company has launched and acquired numerous color cosmetics and skincare brands including Perfect Diary, Little Ondine, Pink Bear, Galénic, DR.WU (its mainland China business), and Eve Lom. Our brands are strategically positioned to capture a wide spectrum of consumer demographics and price points, ranging from the mass market to the prestige and clinical segments. Yatsen thrives on the synergy of brand equity, product strength and operational agility, anchored by a strong commitment to R&D and consumer insights.
For more information, please visit http://ir.yatsenglobal.com.
Yatsen (NYSE:YSG – Get Free Report) and Herbalife (NYSE:HLF – Get Free Report) are both small-cap consumer staples companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, analyst recommendations, valuation and risk.
Analyst Recommendations This is a breakdown of current ratings and price targets for Yatsen and Herbalife, as reported by MarketBeat.
Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Yatsen 1 0 0 0 1.00 Herbalife 0 4 3 0 2.43 Herbalife has a consensus price target of $17.00, suggesting a potential upside of 36.22%. Given Herbalife’s stronger consensus rating and higher possible upside, analysts plainly believe Herbalife is more favorable than Yatsen.
Valuation & Earnings This table compares Yatsen and Herbalife”s gross revenue, earnings per share (EPS) and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Yatsen $614.62 million 0.47 -$11.56 million ($0.21) -14.57 Herbalife $5.04 billion 0.26 $228.30 million $1.55 8.05 Herbalife has higher revenue and earnings than Yatsen. Yatsen is trading at a lower price-to-earnings ratio than Herbalife, indicating that it is currently the more affordable of the two stocks.
Profitability This table compares Yatsen and Herbalife’s net margins, return on equity and return on assets.
Net Margins Return on Equity Return on Assets Yatsen -3.04% -4.54% -3.49% Herbalife 3.16% -43.90% 7.89% Risk & Volatility Yatsen has a beta of -1.55, suggesting that its stock price is 255% less volatile than the S&P 500. Comparatively, Herbalife has a beta of 0.87, suggesting that its stock price is 13% less volatile than the S&P 500.
Summary Herbalife beats Yatsen on 10 of the 12 factors compared between the two stocks.
About Yatsen (Get Free Report)
Yatsen Holding Limited, together with its subsidiaries, engages in the development and sale of beauty products under the Perfect Diary, Little Ondine, Pink Bear, Abby’s Choice, GalÃnic, DR.WU, Eve Lom, and EANTiM brands in the People’s Republic of China. The company offers color cosmetics for lips, eyes, and face; skin care products, including face serums and creams, eye creams, masks, toners, makeup removers, cleansers, ampoules, and anti-acne patches; and beauty tools and kits, sunscreen products, and beauty devices. It sells its products through stores and online channel. The company was formerly known as Mangrove Bay Ecommerce Holding (Cayman) and changed its name to Yatsen Holding Limited in January 2019. Yatsen Holding Limited was founded in 2016 and is headquartered in Guangzhou, China.
About Herbalife (Get Free Report)
Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items. The company also provides weight management products, including meal replacement products, protein shakes, drink mixes, weight loss supplements, healthy snacks, and metabolism boosting teas; targeted nutrition products, which comprise functional beverages, and dietary and nutritional supplements that contain herbs, vitamins, minerals, and other natural ingredients; outer nutrition products, such as facial skin, body, and hair care products; and energy, sports, and fitness products, including N-R-G tea and energy drink products. In addition, it offers literature, promotional, and other materials that comprise start-up kits, sales tools, and educational materials. The company sells its products through sales representatives, independent service providers, and company-operated retail platforms. Herbalife Ltd. was formerly known as Herbalife Nutrition Ltd. and changed its name to Herbalife Ltd. in April 2023. The company was founded in 1980 and is headquartered in Los Angeles, California.
Receive News & Ratings for Yatsen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Yatsen and related companies with MarketBeat.com's FREE daily email newsletter.
, /PRNewswire/ -- Yatsen Group (NYSE: YSG), a world-class beauty innovation pioneer, recently announced a landmark collaboration to bring its flagship brand, Perfect Diary, to Sephora in China. This partnership integrates Yatsen's rigorous scientific infrastructure with the world's leading prestige beauty retailer, marking a significant milestone in Yatsen's continuing evolution into a global beauty technology powerhouse.
Perfect Diary officially lands at Sephora China The collaboration will see Perfect Diary's premium, science-backed portfolio of products making its milestone debut across Sephora's extensive retail network of around 300 outlets, including Tier 1 hubs such as Beijing, Shanghai, Guangzhou, and Shenzhen. This expansion reflects a broader shift in the Chinese beauty market, where sophisticated consumers increasingly prioritize proven efficacy and technological excellence.
Since 2020, Yatsen has invested approximately $100 million (RMB 700 million) in R&D, establishing a robust global innovation ecosystem anchored by advanced research centers in China and Europe.
This commitment to scientific innovation by Yatsen Group is epitomized by the core product lineups driving Perfect Diary's entry into Sephora. As breakthrough products blending biotechnology with beauty, the Perfect Diary Biolip Essence Lipstick 3.0 and Biolip Essence Matte Lipstick 3.0 utilize exclusive patented technology to mimic the skin's biological composition.This creates a functional film on the skin's surface that enhances makeup longevity and reinforces the protective barrier, achieving a seamless fusion of high-performance color and clinical-proved anti-wrinkle skincare benefits.
Concurrently, the Perfect Diary Translucent Blurring Setting Powder features the exclusive Smartlock™ material technology developed jointly with the team at the Shanghai Institute of Ceramics, Chinese Academy of Sciences (SICCAS), enabling targeted and precise oil absorption.
"We are honored to partner with Sephora, a global leader that shares our commitment to setting the highest standards for beauty retail," said David (Jinfeng) Huang, Founder, Chairman, and CEO of Yatsen Group. "This collaboration validates our multi-year strategic pivot toward science-led premiumization. By pairing our deep R&D insights with Sephora's prestige omnichannel network, we are redefining the future of beauty for discerning consumers nationwide."
The partnership also serves as a critical foundation for Yatsen's accelerating internationalization strategy. Future initiatives include expanding Perfect Diary's footprint into Hong Kong SAR and other global markets, further showcasing China's emergence as a premier hub for global beauty innovation.
About Yatsen Group
Yatsen Holding Limited (NYSE: YSG) is a leading China-based beauty group with the vision of becoming a world-class pioneer in beauty innovation. Founded in 2016, the Company has launched and acquired numerous color cosmetics and skincare brands including Perfect Diary, Little Ondine, Pink Bear, Galénic, DR.WU (its mainland China business), and Eve Lom. Our brands are strategically positioned to capture a wide spectrum of consumer demographics and price points, ranging from the mass market to the prestige and clinical segments. Yatsen thrives on the synergy of brand equity, product strength and operational agility, anchored by a strong commitment to R&D and consumer insights.
Website: www.yatsenglobal.com
LinkedIn: www.linkedin.com/company/yatsen
About Sephora
Sephora is the world's leading global prestige beauty retail brand. With 55,000 passionate employees operating in 36 markets, Sephora connects customers and beauty brands within the world's most trusted and dynamic beauty community. We serve a highly engaged community of hundreds of millions of beauty followers across our global omnichannel network of more than 3,400 stores and iconic flagships, and our e-commerce and digital platforms, offering personalized and immersive seamless experiences across every touchpoint. With our curation of close to 500 brands and our own label, Sephora Collection, we offer the most unique and diverse range of prestige beauty products, tailored to our customers' needs from fragrance to make-up, haircare, skincare and beyond, as we constantly reimagine the world of prestige beauty.
Since our inception in 1969 in Limoges, France, and as part of the LVMH Group since 1997, we have been disrupting the prestige beauty retail industry. Today, we continue to break with convention to drive our mission: champion a world of inspiration and inclusion where everyone can celebrate their beauty.
, /PRNewswire/ -- Yatsen Holding Limited ("Yatsen" or the "Company") (NYSE: YSG), a leading China-based beauty group, today announced that the Company has filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the U.S. Securities and Exchange Commission ("SEC") on April 29, 2026.
The annual report is available on the Company's investor relations website at ir.yatsenglobal.com and on the SEC's website at https://www.sec.gov/. The Company will provide hard copies of the annual report, free of charge, to its shareholders and ADS holders upon written request. Requests should be directed to Investor Relations Department, Yatsen Holding Limited, Floor 39, Poly Development Plaza, No. 832 Yue Jiang Zhong Road, Haizhu District, Guangzhou 510335, People's Republic of China.
About Yatsen Holding Limited
Yatsen Holding Limited (NYSE: YSG) is a leading China-based beauty group with the vision of becoming a world-class pioneer in beauty innovation. Founded in 2016, the Company has launched and acquired numerous color cosmetics and skincare brands including Perfect Diary, Little Ondine, Pink Bear, Galénic, DR.WU (its mainland China business), and Eve Lom. Our brands are strategically positioned to capture a wide spectrum of consumer demographics and price points, ranging from the mass market to the prestige and clinical segments. Yatsen thrives on the synergy of brand equity, product strength and operational agility, anchored by a strong commitment to R&D and consumer insights.
For more information, please visit http://ir.yatsenglobal.com/.
, /PRNewswire/ -- In a significant shift reshaping the global beauty industry, Chinese domestic cosmetics brands have captured nearly 60% of the world's second-largest beauty market. This shift is being driven by unprecedented investments in scientific innovation, as well as rapidly evolving consumer expectations. Yatsen Group, one of China's leading beauty companies, today highlighted how its approximately $100 million (RMB 700 million) in R&D investment since 2020 exemplifies the industry's transformation from price-based competition to technology-driven excellence.
Cheng Jing, Chief Scientific Officer of Yatsen Group, during an interview with CGTN (China Global Television Network)
Yatsen Global Innovation R&D Center Over the past decade, Chinese beauty companies have fundamentally strengthened their competitive position, with market share surging from 43% in 2015, according to Frost & Sullivan, to 57% in 2024, according to Xinhua News. This growth reflects a broader consumer evolution: Chinese beauty shoppers are increasingly prioritizing proven efficacy, scientific credibility, and innovation, a shift that domestic brands have actively capitalized on by ramping up investment in R&D and innovation to respond quickly to changing preferences.
As a result, Chinese cosmetics brands are moving away from reliance on cost competition toward building a long-term technological and brand advantage on the global stage.
"This growth is primarily driven by continuous advancements in innovation, brand equity, and product use experience," said Cheng Jing, Chief Scientific Officer of Yatsen Group. "Chinese consumers have become more sophisticated. Their focus has shifted from price to proven efficacy, safety, scientific credibility, and cultural identity."
Importantly, this transformation extends far beyond marketing. Leading Chinese beauty companies are constructing world-class innovation ecosystems.
Yatsen's "1-3-4-6-20" global innovation strategy encompasses three research centers across Shanghai, Guangzhou, and Toulouse, France, with over half of its R&D team holding master's or PhD degrees. The company maintains six joint research laboratories and more than 20 collaborative programs with prestigious institutions including Saint-Louis Hospital in France, as well as Ruijin Hospital, Sun Yat-sen University and Fudan University in China.
"The industry is moving from supply-chain-driven 'product globalization' to innovation-led 'brand globalization,'" added Cheng Jing. "Looking ahead, our goal is to be a world-class beauty innovation pioneer, utilizing a resilient supply chain and 'Glocal' agility to meet the needs of sophisticated consumers worldwide."
This scientific infrastructure addresses what industry analysts identify as the new consumer mandate: products that deliver measurable results backed by rigorous research.
This focus is reflected in Yatsen's portfolio: Perfect Diary leads the emerging "makeup skinification" trend, DR.WU delivers clinic-grade skin renewal, Galénic focuses on cellular-level anti-aging science and Eve Lom leverages advanced neuroscience for emotional skincare benefits.
Global Ambitions, Local Insights
The domestic market success is proving to be a launchpad for international expansion. Since 2021, Yatsen's flagship brand Perfect Diary has gained traction in Southeast Asia and Japan. Its loose powder has consistently ranked among the top three in its category on major e-commerce platforms, according to data from Qoo10 Japan, Amazon Japan, Shopee Vietnam, and TikTok Vietnam—demonstrating that Chinese innovation can compete on performance.
According to one full year of continuous tracking data by Frost & Sullivan, Perfect Diary Biolip Essence Lipstick has been officially recognized as the top-selling lipstick SKU by a Chinese brand worldwide. This achievement stands as a significant milestone showcasing the global rise of technological innovation among Chinese brands.
According to CGTN, Chinese beauty companies are well positioned to benefit from the global shift toward a dual emphasis on efficacy and emotional value. With complete innovation capabilities spanning raw materials to finished products, and supply chain agility that enables rapid response to market trends, domestic brands have transformed former weaknesses into competitive advantages.
About Yatsen Group
Yatsen Holding Limited (NYSE: YSG) is a leading China-based beauty group with the vision of becoming a world-class pioneer in beauty innovation. Founded in 2016, the Company has launched and acquired numerous color cosmetics and skincare brands including Perfect Diary, Little Ondine, Pink Bear, Galénic, DR.WU (its mainland China business), and Eve Lom. Our brands are strategically positioned to capture a wide spectrum of consumer demographics and price points, ranging from the mass market to the prestige and clinical segments. Yatsen thrives on the synergy of brand equity, product strength and operational agility, anchored by a strong commitment to R&D and consumer insights.
, /PRNewswire/ -- Yatsen Holding Limited ("Yatsen" or the "Company") (NYSE: YSG), a leading China-based beauty group, today announced that it will release its unaudited financial results for the first quarter of 2026, on Tuesday, May 26, 2026, before the open of the U.S. markets.
The Company's management will hold a conference call on Tuesday, May 26, 2026 at 7:30 A.M. U.S. Eastern Time (7:30 P.M. Beijing/Hong Kong Time) to discuss the financial results. Listeners may access the call by dialing the following numbers:
United States (toll free):
+1-888-346-8982
International:
+1-412-902-4272
Mainland China (toll free):
400-120-1203
Hong Kong (toll free):
800-905-945
Hong Kong:
+852-3018-4992
A live and archived webcast of the conference call will be available on the Company's investor relations website at http://ir.yatsenglobal.com.
A replay of the conference call will be accessible by phone one hour after the conclusion of the live call at the following numbers, until June 2, 2026:
United States:
+1-855-669-9658
International:
+1-412-317-0088
Replay Access Code:
4359154
About Yatsen Holding Limited
Yatsen Holding Limited (NYSE: YSG) is a leading China-based beauty group with the vision of becoming a world-class pioneer in beauty innovation. Founded in 2016, the Company has launched and acquired numerous color cosmetics and skincare brands including Perfect Diary, Little Ondine, Pink Bear, Galénic, DR.WU (its mainland China business), and Eve Lom. Our brands are strategically positioned to capture a wide spectrum of consumer demographics and price points, ranging from the mass market to the prestige and clinical segments. Yatsen thrives on the synergy of brand equity, product strength and operational agility, anchored by a strong commitment to R&D and consumer insights.
For more information, please visit http://ir.yatsenglobal.com.
, /PRNewswire/ -- Yatsen Holding Limited ("Yatsen" or the "Company") (NYSE: YSG), a leading China-based beauty group, today announced the participation of Hillhouse in the Company's previously announced private placement of RMB-denominated convertible senior notes and warrants (the "Transaction"), and the completion of the first tranche of the Transaction.
Certain affiliates of Hillhouse have joined the investment vehicle for the Transaction (the "Purchaser") as a co-investor, alongside Trustar Capital and Mr. Jinfeng Huang, the Company's founder, Chairman and Chief Executive Officer. The Company and the Purchaser have entered into an amendment to the original note purchase agreement to reflect the expanded investor base.
The closing of the first tranche of the notes (the "First Note") and the corresponding warrants occurred on May 21, 2026. Subject to the satisfaction of applicable closing conditions, the second tranche of the notes is currently expected to be issued later this year. The total aggregate principal amount of the two equal tranches of notes remains unchanged at equivalent to approximately US$120 million. The Company continues to intend to use the net proceeds from the Transaction for product research and development, global supply chain integration, overseas market expansion, strategic mergers and acquisitions, and general corporate purposes.
Mr. Jinfeng Huang, Founder, Chairman and CEO of Yatsen, stated: "We are pleased to welcome Hillhouse's participation in the Transaction. As one of Yatsen's largest and longest-standing shareholders, Hillhouse has supported the Company since 2018. Their continued commitment, together with Trustar Capital and my personal participation, reflects strong confidence in Yatsen's long-term value and strategic direction. With the completion of the first tranche, we are better positioned to execute our growth strategy and create lasting value for shareholders over the long term."
The issuance of the securities under the Transaction has not been registered and is exempt from registration under the Securities Act of 1933, as amended. This press release does not constitute an offer to sell or a solicitation of an offer to buy the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful.
About Yatsen Holding Limited
Yatsen Holding Limited (NYSE: YSG) is a leading China-based beauty group with the vision of becoming a world-class pioneer in beauty innovation. Founded in 2016, the Company has launched and acquired numerous color cosmetics and skincare brands including Perfect Diary, Little Ondine, Pink Bear, Galénic, DR.WU (its mainland China business), and Eve Lom.
For more information, please visit http://ir.yatsenglobal.com/.
Safe Harbor Statement
This announcement contains statements that may constitute "forward-looking" statements which are made pursuant to the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "aims," "future," "intends," "plans," "believes," "estimates," "likely to," and similar statements. The Company may also make written or oral forward-looking statements in its periodic reports to the Securities and Exchange Commission ("SEC"), in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about the Company's beliefs, plans, outlook and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the Company's growth strategies; its future business development, results of operations and financial condition; its ability to continue to roll out popular products and maintain popularity of existing products; its ability to anticipate and respond to changes in industry trends and consumer preferences and behavior in a timely manner; its ability to attract and retain new customers and to increase revenues generated from repeat customers; its expectations regarding demand for and market acceptance of its products and services; its ability to integrate newly-acquired businesses and brands; trends and competition in and relevant government policies and regulations relating to China's beauty market; changes in its revenues and certain cost or expense items; and general economic conditions globally and in China. Further information regarding these and other risks is included in the Company's filings with the SEC. All information provided in this press release is as of the date of this press release, and the Company does not undertake any obligation to update any forward-looking statement, except as required under applicable law.
Conference Call to Be Held at 7:30 A.M. U.S. Eastern Time on May 26, 2026
, /PRNewswire/ -- Yatsen Holding Limited ("Yatsen" or the "Company") (NYSE: YSG), a leading China-based beauty group, today announced its unaudited financial results for the quarter ended March 31, 2026.
First Quarter 2026 Highlights
Total net revenues for the first quarter of 2026 increased by 22.5% to RMB1.02 billion (US$148.0 million) from RMB833.5 million for the prior year period. Total net revenues from Skincare Brands[1] for the first quarter increased by 58.5% to RMB574.2 million (US$83.2 million) from RMB362.4 million for the prior year period. As a percentage of total net revenues, total net revenues from Skincare Brands for the first quarter of 2026 were 56.2%, as compared with 43.5% for the prior year period. Gross margin for the first quarter of 2026 increased to 80.2% from 79.1% for the prior year period. Net loss for the first quarter of 2026 was RMB61.9 million (US$9.0 million), as compared with RMB5.6 million for the prior year period. Non-GAAP net loss[2] for the first quarter of 2026 was RMB57.3 million (US$8.3 million), as compared with non-GAAP net income of RMB7.1 million for the prior year period. Mr. Jinfeng Huang, Founder, Chairman and Chief Executive Officer of Yatsen, stated, "For the first quarter of 2026, we delivered top-line growth that met our previous guidance and demonstrated the ongoing resilience of our multi-brand strategy. Our growth this quarter was primarily propelled by the sustained upward momentum of our Skincare Brands, which experienced substantial year-over-year growth of 58.5%. Guided by our vision to become a world-class pioneer in beauty innovation, we remain committed to strengthening our R&D-led innovation, expanding our hero product families, and positioning our core brands for high-quality growth. Furthermore, we are pleased to note that we completed the first closing of our private placement of convertible notes and warrants in an aggregate principal amount equivalent to approximately US$120 million, with participation from Trustar Capital, Hillhouse and myself, on May 21, 2026. This successful closing serves as a powerful testament to our shareholders' long-term confidence in Yatsen's strategic direction and future value."
Mr. Donghao Yang, Director and Chief Financial Officer of Yatsen, commented, "Our financial results for the first quarter of 2026 reflect encouraging progress in the expansion of our core brands. Total net revenues from our Skincare Brands delivered robust growth, while the combined net revenues of our three major premium and clinical skincare brands, Galénic, DR.WU and Eve Lom, grew by 61.4% year over year. Our gross margin continued its year-over-year expansion and reached 80.2%. This underlying strength underscores the structural health of our business model. While we selectively deployed resources to scale and strengthen our core brands, our commitment to long-term profitability optimization remains unwavering. Moving forward, we are focused on cost optimization to ensure that our top-line expansion efficiently translates into future margin improvement."
First Quarter 2026 Financial Results
Net Revenues
Total net revenues for the first quarter of 2026 increased by 22.5% to RMB1.02 billion (US$148.0 million) from RMB833.5 million for the prior year period. The increase was primarily due to a 58.5% year-over-year increase in net revenues from Skincare Brands, partially offset by a 5.0% year-over-year decrease in net revenues from Color Cosmetics Brands.[3]
Gross Profit and Gross Margin
Gross profit for the first quarter of 2026 increased by 24.3% to RMB819.2 million (US$118.8 million) from RMB659.1 million for the prior year period. Gross margin for the first quarter of 2026 increased to 80.2% from 79.1% for the prior year period.
Operating Expenses
Total operating expenses for the first quarter of 2026 increased by 32.5% to RMB918.1 million (US$133.1 million) from RMB693.2 million for the prior year period. As a percentage of total net revenues, total operating expenses for the first quarter of 2026 were 89.9%, as compared with 83.2% for the prior year period.
Fulfillment Expenses. Fulfillment expenses for the first quarter of 2026 were RMB61.1 million (US$8.9 million), as compared with RMB51.8 million for the prior year period. As a percentage of total net revenues, fulfillment expenses for the first quarter of 2026 decreased to 6.0% from 6.2% for the prior year period. The decrease was primarily due to further improvements in logistics efficiency. Selling and Marketing Expenses. Selling and marketing expenses for the first quarter of 2026 were RMB737.2 million (US$106.9 million), as compared with RMB553.8 million for the prior year period. As a percentage of total net revenues, selling and marketing expenses for the first quarter of 2026 increased to 72.2% from 66.4% for the prior year period. The increase was primarily driven by investments in broadening consumer awareness and building long-term brand equity of our core brands, coupled with higher traffic acquisition costs on the Douyin platform. General and Administrative Expenses. General and administrative expenses for the first quarter of 2026 were RMB80.3 million (US$11.6 million), as compared with RMB64.9 million for the prior year period. As a percentage of total net revenues, general and administrative expenses for the first quarter of 2026 were 7.9% as compared with 7.8% for the prior year period, remaining largely flat. Research and Development Expenses. Research and development expenses for the first quarter of 2026 were RMB39.4 million (US$5.7 million), as compared with RMB22.6 million for the prior year period. As a percentage of total net revenues, research and development expenses for the first quarter of 2026 increased to 3.9% from 2.7% for the prior year period. The increase was primarily driven by higher payroll expenses resulting from a rise in research and development headcount. Loss / Income from Operations
Loss from operations for the first quarter of 2026 was RMB99.0 million (US$14.3 million), as compared with RMB34.1 million for the prior year period. Operating loss margin was 9.7%, as compared with 4.1% for the prior year period.
Non-GAAP loss from operations[4] for the first quarter of 2026 was RMB84.6 million (US$12.3 million), as compared with RMB14.9 million for the prior year period. Non-GAAP operating loss margin[5] was 8.3%, as compared with 1.8% for the prior year period.
Net Loss / Income
Net loss for the first quarter of 2026 was RMB61.9 million (US$9.0 million), as compared with RMB5.6 million for the prior year period. Net loss margin was 6.1%, as compared with 0.7% for the prior year period. Net loss attributable to Yatsen's ordinary shareholders per diluted ADS[6] for the first quarter of 2026 was RMB0.64 (US$0.09), as compared with RMB0.06 for the prior year period.
Non-GAAP net loss for the first quarter of 2026 was RMB57.3 million (US$8.3 million), as compared with non-GAAP net income of RMB7.1 million for the prior year period. Non-GAAP net loss margin was 5.6%, as compared with non-GAAP net income margin of 0.9% for the prior year period. Non-GAAP net loss attributable to Yatsen's ordinary shareholders per diluted ADS[7] for the first quarter of 2026 was RMB0.60 (US$0.09), as compared with non-GAAP net income attributable to Yatsen's ordinary shareholders per diluted ADS of RMB0.07 for the prior year period.
Balance Sheet and Cash Flow
As of March 31, 2026, the Company had cash, restricted cash and short-term investments of RMB934.2 million (US$135.4 million), as compared with RMB1.05 billion as of December 31, 2025.
Net cash used in operating activities for the first quarter of 2026 was RMB90.0 million (US$13.0 million), as compared with net cash generated from operating activities of RMB23.8 million for the prior year period.
Business Outlook
For the second quarter of 2026, the Company expects its total net revenues to be between RMB1.20 billion and RMB1.30 billion, representing a year-over-year increase of approximately 10% to 20%. These forecasts reflect the Company's current and preliminary views on the market and operational conditions, which are subject to change.
Exchange Rate
This announcement contains translations of certain Renminbi ("RMB") amounts into U.S. dollars ("US$") at specified rates solely for the convenience of the reader. Unless otherwise noted, all translations from RMB to US$ were made at a rate of RMB6.8980 to US$1.00, the exchange rate in effect as of March 31, 2026, as set forth in the H.10 statistical release of The Board of Governors of the Federal Reserve System. The Company makes no representation that any RMB or US$ amounts could have been, or could be, converted into US$ or RMB, as the case may be, at any particular rate, or at all.
[1] Include net revenues from Galénic, DR.WU (its mainland China business), Eve Lom and other skincare brands of the Company.
[2] Non-GAAP net income (loss) is a non-GAAP financial measure. Non-GAAP net income (loss) is defined as net income (loss) excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions, (iii) revaluation of investments on the share of equity method investments, (iv) impairment of goodwill, (v) impairment of investments and (vi) tax effects on non-GAAP adjustments.
[3] Include Perfect Diary, Little Ondine, Pink Bear and other color cosmetics brands of the Company.
[4] Non-GAAP income (loss) from operations is a non-GAAP financial measure. Non-GAAP income (loss) from operations is defined as income (loss) from operations excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions and (iii) impairment of goodwill.
[5] Non-GAAP operating income (loss) margin is a non-GAAP financial measure, which is defined as non-GAAP net income (loss) from operations as a percentage of total net revenues.
[6] ADS refers to American depositary shares, each of which represents twenty Class A ordinary shares.
[7] Non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS is a non-GAAP financial measure. Non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS is defined as non-GAAP net income (loss) attributable to ordinary shareholders divided by the weighted average number of diluted ADS outstanding for computing diluted earnings per ADS. Non-GAAP net income (loss) attributable to ordinary shareholders is defined as net income (loss) attributable to ordinary shareholders excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions, (iii) revaluation of investments on the share of equity method investments, (iv) impairment of goodwill, (v) impairment of investments, (vi) tax effects on non-GAAP adjustments and (vii) accretion to redeemable non-controlling interests.
Conference Call Information
The Company's management will hold a conference call on Tuesday, May 26, 2026, at 7:30 A.M. U.S. Eastern Time or 7:30 P.M. Beijing Time to discuss its financial results and operating performance for the first quarter of 2026.
United States (toll free):
+1-888-346-8982
International:
+1-412-902-4272
Mainland China (toll free):
400-120-1203
Hong Kong, SAR (toll free):
800-905-945
Hong Kong, SAR:
+852-3018-4992
The replay will be accessible through Tuesday, June 2, by dialing the following numbers:
United States:
+1-855-669-9658
International:
+1-412-317-0088
Replay Access Code:
4359154
A live and archived webcast of the conference call will also be available on the Company's investor relations website at http://ir.yatsenglobal.com.
About Yatsen Holding Limited
Yatsen Holding Limited (NYSE: YSG) is a leading China-based beauty group with the vision of becoming a world-class pioneer in beauty innovation. Founded in 2016, the Company has launched and acquired numerous color cosmetics and skincare brands including Perfect Diary, Little Ondine, Pink Bear, Galénic, DR.WU (its mainland China business), and Eve Lom. Our brands are strategically positioned to capture a wide spectrum of consumer demographics and price points, ranging from the mass market to the prestige and clinical segments. Yatsen thrives on the synergy of brand equity, product strength and operational agility, anchored by a strong commitment to R&D and consumer insights.
For more information, please visit http://ir.yatsenglobal.com.
Use of Non-GAAP Financial Measures
The Company uses non-GAAP income (loss) from operations, non-GAAP operating income (loss) margin, non-GAAP net income (loss), non-GAAP net income (loss) margin, non-GAAP net income (loss) attributable to ordinary shareholders and non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS, each a non-GAAP financial measure, in reviewing and assessing its operating performance. The presentation of these non-GAAP financial measures is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with U.S. GAAP. The Company presents these non-GAAP financial measures because they are used by the management to evaluate operating performance and formulate business plans. Non-GAAP financial measures help identify underlying trends in its business, provide further information about its results of operations, and enhance the overall understanding of its past performance and future prospects. The Company defines non-GAAP income (loss) from operations as income (loss) from operations excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions and (iii) impairment of goodwill. Non-GAAP operating income (loss) margin is non-GAAP income (loss) from operations as a percentage of total net revenues. The Company defines non-GAAP net income (loss) as net income (loss) excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions, (iii) revaluation of investments on the share of equity method investments, (iv) impairment of goodwill, (v) impairment of investments and (vi) tax effects on non-GAAP adjustments. Non-GAAP net income (loss) margin is non-GAAP net income (loss) as a percentage of total net revenues. The Company defines non-GAAP net income (loss) attributable to ordinary shareholders as net income (loss) attributable to ordinary shareholders excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions, (iii) revaluation of investments on the share of equity method investments, (iv) impairment of goodwill, (v) impairment of investments, (vi) tax effects on non-GAAP adjustments and (vii) accretion to redeemable non-controlling interests. Non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS is computed using non-GAAP net income (loss) attributable to ordinary shareholders divided by weighted average number of diluted ADS outstanding for computing diluted earnings per ADS.
However, the non-GAAP financial measures have limitations as analytical tools as the non-GAAP financial measures are not presented in accordance with U.S. GAAP and may differ from the non-GAAP information used by other companies, including peer companies, and therefore their comparability may be limited. The Company compensates for these limitations by reconciling the non-GAAP financial measures to the nearest U.S. GAAP performance measure, all of which should be considered when evaluating performance. The Company encourages investors and others to review its financial information in its entirety and not rely on a single financial measure. Reconciliations of Yatsen's non-GAAP financial measures to the most comparable U.S. GAAP measure are included at the end of this press release.
Safe Harbor Statement
This announcement contains statements that may constitute "forward-looking" statements which are made pursuant to the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "aims," "future," "intends," "plans," "believes," "estimates," "likely to," and similar statements. The Company may also make written or oral forward-looking statements in its periodic reports to the Securities and Exchange Commission ("SEC"), in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about the Company's beliefs, plans, outlook and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the Company's growth strategies; its future business development, results of operations and financial condition; its ability to continue to roll out popular products and maintain popularity of existing products; its ability to anticipate and respond to changes in industry trends and consumer preferences and behavior in a timely manner; its ability to attract and retain new customers and to increase revenues generated from repeat customers; its expectations regarding demand for and market acceptance of its products and services; its ability to integrate newly-acquired businesses and brands; trends and competition in and relevant government policies and regulations relating to China's beauty market; changes in its revenues and certain cost or expense items; and general economic conditions globally and in China. Further information regarding these and other risks is included in the Company's filings with the SEC. All information provided in this press release is as of the date of this press release, and the Company does not undertake any obligation to update any forward-looking statement, except as required under applicable law.
(All amounts in thousands, except for share, per share data or otherwise noted)
December 31,
March 31,
March 31,
2025
2026
2026
RMB'000
RMB'000
USD'000
Assets
Current assets
Cash and cash equivalents
765,379
876,144
127,014
Restricted Cash
42,117
58,036
8,413
Short-term investments
246,008
-
-
Accounts receivable, net
220,870
183,701
26,631
Inventories, net
508,730
573,339
83,117
Prepayments and other current assets
450,970
440,103
63,802
Amounts due from related parties
114
53
8
Total current assets
2,234,188
2,131,376
308,985
Non-current assets
Investments
653,560
667,995
96,839
Property and equipment, net
77,014
71,982
10,435
Goodwill, net
155,029
155,029
22,474
Intangible assets, net
537,509
509,249
73,826
Deferred tax assets
1,435
1,040
151
Right-of-use assets, net
173,915
158,718
23,009
Other non-current assets
14,332
22,151
3,211
Total non-current assets
1,612,794
1,586,164
229,945
Total assets
3,846,982
3,717,540
538,930
Liabilities, redeemable non-controlling interests and shareholders'
equity
Current liabilities
Accounts and notes payable
149,371
154,805
22,442
Advances from customers
28,821
29,480
4,274
Accrued expenses and other liabilities
348,700
322,994
46,824
Amounts due to related parties
21,262
19,412
2,814
Income tax payables
13,690
13,778
1,997
Lease liabilities due within one year
53,435
53,039
7,689
Total current liabilities
615,279
593,508
86,040
Non-current liabilities
Deferred tax liabilities
107,906
106,052
15,374
Lease liabilities
123,157
110,184
15,973
Total non-current liabilities
231,063
216,236
31,347
Total liabilities
846,342
809,744
117,387
Redeemable non-controlling interests
1,337
1,337
194
Shareholders' equity
Ordinary Shares (US$0.00001 par value; 10,000,000,000 ordinary
shares authorized, comprising of 6,000,000,000 Class A ordinary
shares, 960,852,606 Class B ordinary shares and 3,039,147,394
shares each of such classes to be designated as of December 31,
2025 and March 31, 2026; 2,096,600,883 Class A shares and
600,572,880 Class B ordinary shares issued as of December 31,
2025 and March 31, 2026; 1,276,663,163 Class A ordinary shares
and 600,572,880 Class B ordinary shares outstanding as of
December 31, 2025, 1,275,536,483 Class A ordinary shares and
600,572,880 Class B ordinary shares outstanding as of March 31,
2026)
173
173
25
Treasury shares
(1,250,678)
(1,253,378)
(181,702)
Additional paid-in capital
12,296,367
12,297,001
1,782,691
Statutory reserve
31,527
31,527
4,570
Accumulated deficit
(8,141,545)
(8,202,059)
(1,189,049)
Accumulated other comprehensive income
74,760
45,910
6,657
Total Yatsen Holding Limited shareholders' equity
3,010,604
2,919,174
423,192
Non-controlling interests
(11,301)
(12,715)
(1,843)
Total shareholders' equity
2,999,303
2,906,459
421,349
Total liabilities, redeemable non-controlling interests and
shareholders' equity
3,846,982
3,717,540
538,930
YATSEN HOLDING LIMITED
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(All amounts in thousands, except for share, per share data or otherwise noted)
For the Three Months Ended March 31,
2025
2026
2026
RMB'000
RMB'000
USD'000
Total net revenues
833,533
1,020,986
148,012
Total cost of revenues
(174,406)
(201,797)
(29,254)
Gross profit
659,127
819,189
118,758
Operating expenses:
Fulfilment expenses
(51,843)
(61,138)
(8,863)
Selling and marketing expenses
(553,815)
(737,236)
(106,877)
General and administrative expenses
(64,883)
(80,326)
(11,645)
Research and development expenses
(22,637)
(39,440)
(5,718)
Total operating expenses
(693,178)
(918,140)
(133,103)
Loss from operations
(34,051)
(98,951)
(14,345)
Financial income
10,606
10,741
1,557
Foreign currency exchange gain (loss)
10,664
(3,198)
(464)
Income from equity method investments, net
2,505
12,389
1,796
Other income, net
4,242
18,466
2,677
Loss before income tax expenses
(6,034)
(60,553)
(8,779)
Income tax benefits (expenses)
433
(1,375)
(199)
Net loss
(5,601)
(61,928)
(8,978)
Net loss attributable to non-controlling interests and redeemable non-
controlling interests
298
1,414
205
Net loss attributable to Yatsen's shareholders
(5,303)
(60,514)
(8,773)
Shares used in calculating loss per share (1):
Weighted average number of Class A and Class B ordinary shares:
Basic
1,837,466,068
1,876,901,662
1,876,901,662
Diluted
1,837,466,068
1,876,901,662
1,876,901,662
Net loss per Class A and Class B ordinary share
Basic
(0.00)
(0.03)
(0.00)
Diluted
(0.00)
(0.03)
(0.00)
Net loss per ADS (20 ordinary shares equal to 1 ADS) (2)
Basic
(0.06)
(0.64)
(0.09)
Diluted
(0.06)
(0.64)
(0.09)
For the Three Months Ended March 31,
2025
2026
2026
Share-based compensation expenses are included in the
operating expenses as follows:
RMB'000
RMB'000
USD'000
Fulfilment expenses
98
249
36
Selling and marketing expenses
757
148
21
General and administrative expenses
7,731
2,003
290
Research and development expenses
40
1,159
168
Total
8,626
3,559
515
(1) Authorized share capital is re-classified and re-designated into Class A ordinary shares and Class B ordinary shares, with each
Class A ordinary share being entitled to one vote and each Class B ordinary share being entitled to twenty votes on all matters that
are subject to shareholder vote.
YATSEN HOLDING LIMITED
UNAUDITED RECONCILIATIONS OF GAAP AND NON-GAAP RESULTS
(All amounts in thousands, except for share, per share data or otherwise noted)
For the Three Months Ended March 31,
2025
2026
2026
RMB'000
RMB'000
USD'000
Loss from operations
(34,051)
(98,951)
(14,345)
Share-based compensation expenses
8,626
3,559
515
Amortization of intangible assets resulting from assets and business
acquisitions
10,561
10,759
1,560
Non-GAAP loss from operations
(14,864)
(84,633)
(12,270)
Net loss
(5,601)
(61,928)
(8,978)
Share-based compensation expenses
8,626
3,559
515
Amortization of intangible assets resulting from assets and business
acquisitions
10,561
10,759
1,560
Revaluation of investments on the share of equity method
investments
(6,010)
(10,469)
(1,518)
Tax effects on non-GAAP adjustments
(433)
829
120
Non-GAAP net income (loss)
7,143
(57,250)
(8,301)
Net loss attributable to Yatsen's shareholders
(5,303)
(60,514)
(8,773)
Share-based compensation expenses
8,626
3,559
515
Amortization of intangible assets resulting from assets and business
acquisitions
10,179
10,473
1,518
Revaluation of investments on the share of equity method
investments
(6,010)
(10,469)
(1,518)
Tax effects on non-GAAP adjustments
(405)
829
120
Non-GAAP net income (loss) attributable to Yatsen's
shareholders
7,087
(56,122)
(8,138)
Shares used in calculating loss per share:
Weighted average number of Class A and Class B ordinary shares:
Basic
1,837,466,068
1,876,901,662
1,876,901,662
Diluted
1,953,491,427
1,876,901,662
1,876,901,662
Non-GAAP net income (loss) attributable to ordinary
shareholders per Class A and Class B ordinary share
Basic
0.00
(0.03)
(0.00)
Diluted
0.00
(0.03)
(0.00)
Non-GAAP net income (loss) attributable to ordinary
shareholders per ADS (20 ordinary shares equal to 1 ADS) (1)
Yatsen Announces First Quarter 2026 Financial Results PR Newswire
GUANGZHOU, China, May 26, 2026
Conference Call to Be Held at 7:30 A.M. U.S. Eastern Time on May 26, 2026
, /PRNewswire/ -- Yatsen Holding Limited ("Yatsen" or the "Company") (NYSE: YSG), a leading China-based beauty group, today announced its unaudited financial results for the quarter ended March 31, 2026.
First Quarter 2026 Highlights
Total net revenues for the first quarter of 2026 increased by 22.5% to RMB1.02 billion (US$148.0 million) from RMB833.5 million for the prior year period.Total net revenues from Skincare Brands[1] for the first quarter increased by 58.5% to RMB574.2 million (US$83.2 million) from RMB362.4 million for the prior year period. As a percentage of total net revenues, total net revenues from Skincare Brands for the first quarter of 2026 were 56.2%, as compared with 43.5% for the prior year period.Gross margin for the first quarter of 2026 increased to 80.2% from 79.1% for the prior year period.Net loss for the first quarter of 2026 was RMB61.9 million (US$9.0 million), as compared with RMB5.6 million for the prior year period. Non-GAAP net loss[2] for the first quarter of 2026 was RMB57.3 million (US$8.3 million), as compared with non-GAAP net income of RMB7.1 million for the prior year period.Mr. Jinfeng Huang, Founder, Chairman and Chief Executive Officer of Yatsen, stated, "For the first quarter of 2026, we delivered top-line growth that met our previous guidance and demonstrated the ongoing resilience of our multi-brand strategy. Our growth this quarter was primarily propelled by the sustained upward momentum of our Skincare Brands, which experienced substantial year-over-year growth of 58.5%. Guided by our vision to become a world-class pioneer in beauty innovation, we remain committed to strengthening our R&D-led innovation, expanding our hero product families, and positioning our core brands for high-quality growth. Furthermore, we are pleased to note that we completed the first closing of our private placement of convertible notes and warrants in an aggregate principal amount equivalent to approximately US$120 million, with participation from Trustar Capital, Hillhouse and myself, on May 21, 2026. This successful closing serves as a powerful testament to our shareholders' long-term confidence in Yatsen's strategic direction and future value."
Mr. Donghao Yang, Director and Chief Financial Officer of Yatsen, commented, "Our financial results for the first quarter of 2026 reflect encouraging progress in the expansion of our core brands. Total net revenues from our Skincare Brands delivered robust growth, while the combined net revenues of our three major premium and clinical skincare brands, Galénic, DR.WU and Eve Lom, grew by 61.4% year over year. Our gross margin continued its year-over-year expansion and reached 80.2%. This underlying strength underscores the structural health of our business model. While we selectively deployed resources to scale and strengthen our core brands, our commitment to long-term profitability optimization remains unwavering. Moving forward, we are focused on cost optimization to ensure that our top-line expansion efficiently translates into future margin improvement."
First Quarter 2026 Financial Results
Net Revenues
Total net revenues for the first quarter of 2026 increased by 22.5% to RMB1.02 billion (US$148.0 million) from RMB833.5 million for the prior year period. The increase was primarily due to a 58.5% year-over-year increase in net revenues from Skincare Brands, partially offset by a 5.0% year-over-year decrease in net revenues from Color Cosmetics Brands.[3]
Gross Profit and Gross Margin
Gross profit for the first quarter of 2026 increased by 24.3% to RMB819.2 million (US$118.8 million) from RMB659.1 million for the prior year period. Gross margin for the first quarter of 2026 increased to 80.2% from 79.1% for the prior year period.
Operating Expenses
Total operating expenses for the first quarter of 2026 increased by 32.5% to RMB918.1 million (US$133.1 million) from RMB693.2 million for the prior year period. As a percentage of total net revenues, total operating expenses for the first quarter of 2026 were 89.9%, as compared with 83.2% for the prior year period.
Fulfillment Expenses. Fulfillment expenses for the first quarter of 2026 were RMB61.1 million (US$8.9 million), as compared with RMB51.8 million for the prior year period. As a percentage of total net revenues, fulfillment expenses for the first quarter of 2026 decreased to 6.0% from 6.2% for the prior year period. The decrease was primarily due to further improvements in logistics efficiency.Selling and Marketing Expenses. Selling and marketing expenses for the first quarter of 2026 were RMB737.2 million (US$106.9 million), as compared with RMB553.8 million for the prior year period. As a percentage of total net revenues, selling and marketing expenses for the first quarter of 2026 increased to 72.2% from 66.4% for the prior year period. The increase was primarily driven by investments in broadening consumer awareness and building long-term brand equity of our core brands, coupled with higher traffic acquisition costs on the Douyin platform.General and Administrative Expenses. General and administrative expenses for the first quarter of 2026 were RMB80.3 million (US$11.6 million), as compared with RMB64.9 million for the prior year period. As a percentage of total net revenues, general and administrative expenses for the first quarter of 2026 were 7.9% as compared with 7.8% for the prior year period, remaining largely flat.Research and Development Expenses. Research and development expenses for the first quarter of 2026 were RMB39.4 million (US$5.7 million), as compared with RMB22.6 million for the prior year period. As a percentage of total net revenues, research and development expenses for the first quarter of 2026 increased to 3.9% from 2.7% for the prior year period. The increase was primarily driven by higher payroll expenses resulting from a rise in research and development headcount.Loss / Income from Operations
Loss from operations for the first quarter of 2026 was RMB99.0 million (US$14.3 million), as compared with RMB34.1 million for the prior year period. Operating loss margin was 9.7%, as compared with 4.1% for the prior year period.
Non-GAAP loss from operations[4] for the first quarter of 2026 was RMB84.6 million (US$12.3 million), as compared with RMB14.9 million for the prior year period. Non-GAAP operating loss margin[5] was 8.3%, as compared with 1.8% for the prior year period.
Net Loss / Income
Net loss for the first quarter of 2026 was RMB61.9 million (US$9.0 million), as compared with RMB5.6 million for the prior year period. Net loss margin was 6.1%, as compared with 0.7% for the prior year period. Net loss attributable to Yatsen's ordinary shareholders per diluted ADS[6] for the first quarter of 2026 was RMB0.64 (US$0.09), as compared with RMB0.06 for the prior year period.
Non-GAAP net loss for the first quarter of 2026 was RMB57.3 million (US$8.3 million), as compared with non-GAAP net income of RMB7.1 million for the prior year period. Non-GAAP net loss margin was 5.6%, as compared with non-GAAP net income margin of 0.9% for the prior year period. Non-GAAP net loss attributable to Yatsen's ordinary shareholders per diluted ADS[7] for the first quarter of 2026 was RMB0.60 (US$0.09), as compared with non-GAAP net income attributable to Yatsen's ordinary shareholders per diluted ADS of RMB0.07 for the prior year period.
Balance Sheet and Cash Flow
As of March 31, 2026, the Company had cash, restricted cash and short-term investments of RMB934.2 million (US$135.4 million), as compared with RMB1.05 billion as of December 31, 2025.
Net cash used in operating activities for the first quarter of 2026 was RMB90.0 million (US$13.0 million), as compared with net cash generated from operating activities of RMB23.8 million for the prior year period.
Business Outlook
For the second quarter of 2026, the Company expects its total net revenues to be between RMB1.20 billion and RMB1.30 billion, representing a year-over-year increase of approximately 10% to 20%. These forecasts reflect the Company's current and preliminary views on the market and operational conditions, which are subject to change.
Exchange Rate
This announcement contains translations of certain Renminbi ("RMB") amounts into U.S. dollars ("US$") at specified rates solely for the convenience of the reader. Unless otherwise noted, all translations from RMB to US$ were made at a rate of RMB6.8980 to US$1.00, the exchange rate in effect as of March 31, 2026, as set forth in the H.10 statistical release of The Board of Governors of the Federal Reserve System. The Company makes no representation that any RMB or US$ amounts could have been, or could be, converted into US$ or RMB, as the case may be, at any particular rate, or at all.
[1] Include net revenues from Galénic, DR.WU (its mainland China business), Eve Lom and other skincare brands of the Company.
[2] Non-GAAP net income (loss) is a non-GAAP financial measure. Non-GAAP net income (loss) is defined as net income (loss) excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions, (iii) revaluation of investments on the share of equity method investments, (iv) impairment of goodwill, (v) impairment of investments and (vi) tax effects on non-GAAP adjustments.
[3] Include Perfect Diary, Little Ondine, Pink Bear and other color cosmetics brands of the Company.
[4] Non-GAAP income (loss) from operations is a non-GAAP financial measure. Non-GAAP income (loss) from operations is defined as income (loss) from operations excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions and (iii) impairment of goodwill.
[5] Non-GAAP operating income (loss) margin is a non-GAAP financial measure, which is defined as non-GAAP net income (loss) from operations as a percentage of total net revenues.
[6] ADS refers to American depositary shares, each of which represents twenty Class A ordinary shares.
[7] Non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS is a non-GAAP financial measure. Non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS is defined as non-GAAP net income (loss) attributable to ordinary shareholders divided by the weighted average number of diluted ADS outstanding for computing diluted earnings per ADS. Non-GAAP net income (loss) attributable to ordinary shareholders is defined as net income (loss) attributable to ordinary shareholders excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions, (iii) revaluation of investments on the share of equity method investments, (iv) impairment of goodwill, (v) impairment of investments, (vi) tax effects on non-GAAP adjustments and (vii) accretion to redeemable non-controlling interests.
Conference Call Information
The Company's management will hold a conference call on Tuesday, May 26, 2026, at 7:30 A.M. U.S. Eastern Time or 7:30 P.M. Beijing Time to discuss its financial results and operating performance for the first quarter of 2026.
United States (toll free):
+1-888-346-8982
International:
+1-412-902-4272
Mainland China (toll free):
400-120-1203
Hong Kong, SAR (toll free):
800-905-945
Hong Kong, SAR:
+852-3018-4992
The replay will be accessible through Tuesday, June 2, by dialing the following numbers:
United States:
+1-855-669-9658
International:
+1-412-317-0088
Replay Access Code:
4359154
A live and archived webcast of the conference call will also be available on the Company's investor relations website at http://ir.yatsenglobal.com.
About Yatsen Holding Limited
Yatsen Holding Limited (NYSE: YSG) is a leading China-based beauty group with the vision of becoming a world-class pioneer in beauty innovation. Founded in 2016, the Company has launched and acquired numerous color cosmetics and skincare brands including Perfect Diary, Little Ondine, Pink Bear, Galénic, DR.WU (its mainland China business), and Eve Lom. Our brands are strategically positioned to capture a wide spectrum of consumer demographics and price points, ranging from the mass market to the prestige and clinical segments. Yatsen thrives on the synergy of brand equity, product strength and operational agility, anchored by a strong commitment to R&D and consumer insights.
For more information, please visit http://ir.yatsenglobal.com.
Use of Non-GAAP Financial Measures
The Company uses non-GAAP income (loss) from operations, non-GAAP operating income (loss) margin, non-GAAP net income (loss), non-GAAP net income (loss) margin, non-GAAP net income (loss) attributable to ordinary shareholders and non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS, each a non-GAAP financial measure, in reviewing and assessing its operating performance. The presentation of these non-GAAP financial measures is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with U.S. GAAP. The Company presents these non-GAAP financial measures because they are used by the management to evaluate operating performance and formulate business plans. Non-GAAP financial measures help identify underlying trends in its business, provide further information about its results of operations, and enhance the overall understanding of its past performance and future prospects. The Company defines non-GAAP income (loss) from operations as income (loss) from operations excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions and (iii) impairment of goodwill. Non-GAAP operating income (loss) margin is non-GAAP income (loss) from operations as a percentage of total net revenues. The Company defines non-GAAP net income (loss) as net income (loss) excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions, (iii) revaluation of investments on the share of equity method investments, (iv) impairment of goodwill, (v) impairment of investments and (vi) tax effects on non-GAAP adjustments. Non-GAAP net income (loss) margin is non-GAAP net income (loss) as a percentage of total net revenues. The Company defines non-GAAP net income (loss) attributable to ordinary shareholders as net income (loss) attributable to ordinary shareholders excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions, (iii) revaluation of investments on the share of equity method investments, (iv) impairment of goodwill, (v) impairment of investments, (vi) tax effects on non-GAAP adjustments and (vii) accretion to redeemable non-controlling interests. Non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS is computed using non-GAAP net income (loss) attributable to ordinary shareholders divided by weighted average number of diluted ADS outstanding for computing diluted earnings per ADS.
However, the non-GAAP financial measures have limitations as analytical tools as the non-GAAP financial measures are not presented in accordance with U.S. GAAP and may differ from the non-GAAP information used by other companies, including peer companies, and therefore their comparability may be limited. The Company compensates for these limitations by reconciling the non-GAAP financial measures to the nearest U.S. GAAP performance measure, all of which should be considered when evaluating performance. The Company encourages investors and others to review its financial information in its entirety and not rely on a single financial measure. Reconciliations of Yatsen's non-GAAP financial measures to the most comparable U.S. GAAP measure are included at the end of this press release.
Safe Harbor Statement
This announcement contains statements that may constitute "forward-looking" statements which are made pursuant to the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "aims," "future," "intends," "plans," "believes," "estimates," "likely to," and similar statements. The Company may also make written or oral forward-looking statements in its periodic reports to the Securities and Exchange Commission ("SEC"), in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about the Company's beliefs, plans, outlook and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the Company's growth strategies; its future business development, results of operations and financial condition; its ability to continue to roll out popular products and maintain popularity of existing products; its ability to anticipate and respond to changes in industry trends and consumer preferences and behavior in a timely manner; its ability to attract and retain new customers and to increase revenues generated from repeat customers; its expectations regarding demand for and market acceptance of its products and services; its ability to integrate newly-acquired businesses and brands; trends and competition in and relevant government policies and regulations relating to China's beauty market; changes in its revenues and certain cost or expense items; and general economic conditions globally and in China. Further information regarding these and other risks is included in the Company's filings with the SEC. All information provided in this press release is as of the date of this press release, and the Company does not undertake any obligation to update any forward-looking statement, except as required under applicable law.
(All amounts in thousands, except for share, per share data or otherwise noted)
December 31,
March 31,
March 31,
2025
2026
2026
RMB'000
RMB'000
USD'000
Assets
Current assets
Cash and cash equivalents
765,379
876,144
127,014
Restricted Cash
42,117
58,036
8,413
Short-term investments
246,008
-
-
Accounts receivable, net
220,870
183,701
26,631
Inventories, net
508,730
573,339
83,117
Prepayments and other current assets
450,970
440,103
63,802
Amounts due from related parties
114
53
8
Total current assets
2,234,188
2,131,376
308,985
Non-current assets
Investments
653,560
667,995
96,839
Property and equipment, net
77,014
71,982
10,435
Goodwill, net
155,029
155,029
22,474
Intangible assets, net
537,509
509,249
73,826
Deferred tax assets
1,435
1,040
151
Right-of-use assets, net
173,915
158,718
23,009
Other non-current assets
14,332
22,151
3,211
Total non-current assets
1,612,794
1,586,164
229,945
Total assets
3,846,982
3,717,540
538,930
Liabilities, redeemable non-controlling interests and shareholders'
equity
Current liabilities
Accounts and notes payable
149,371
154,805
22,442
Advances from customers
28,821
29,480
4,274
Accrued expenses and other liabilities
348,700
322,994
46,824
Amounts due to related parties
21,262
19,412
2,814
Income tax payables
13,690
13,778
1,997
Lease liabilities due within one year
53,435
53,039
7,689
Total current liabilities
615,279
593,508
86,040
Non-current liabilities
Deferred tax liabilities
107,906
106,052
15,374
Lease liabilities
123,157
110,184
15,973
Total non-current liabilities
231,063
216,236
31,347
Total liabilities
846,342
809,744
117,387
Redeemable non-controlling interests
1,337
1,337
194
Shareholders' equity
Ordinary Shares (US$0.00001 par value; 10,000,000,000 ordinary
shares authorized, comprising of 6,000,000,000 Class A ordinary
shares, 960,852,606 Class B ordinary shares and 3,039,147,394
shares each of such classes to be designated as of December 31,
2025 and March 31, 2026; 2,096,600,883 Class A shares and
600,572,880 Class B ordinary shares issued as of December 31,
2025 and March 31, 2026; 1,276,663,163 Class A ordinary shares
and 600,572,880 Class B ordinary shares outstanding as of
December 31, 2025, 1,275,536,483 Class A ordinary shares and
600,572,880 Class B ordinary shares outstanding as of March 31,
2026)
173
173
25
Treasury shares
(1,250,678)
(1,253,378)
(181,702)
Additional paid-in capital
12,296,367
12,297,001
1,782,691
Statutory reserve
31,527
31,527
4,570
Accumulated deficit
(8,141,545)
(8,202,059)
(1,189,049)
Accumulated other comprehensive income
74,760
45,910
6,657
Total Yatsen Holding Limited shareholders' equity
3,010,604
2,919,174
423,192
Non-controlling interests
(11,301)
(12,715)
(1,843)
Total shareholders' equity
2,999,303
2,906,459
421,349
Total liabilities, redeemable non-controlling interests and
shareholders' equity
3,846,982
3,717,540
538,930
YATSEN HOLDING LIMITED
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(All amounts in thousands, except for share, per share data or otherwise noted)
For the Three Months Ended March 31,
2025
2026
2026
RMB'000
RMB'000
USD'000
Total net revenues
833,533
1,020,986
148,012
Total cost of revenues
(174,406)
(201,797)
(29,254)
Gross profit
659,127
819,189
118,758
Operating expenses:
Fulfilment expenses
(51,843)
(61,138)
(8,863)
Selling and marketing expenses
(553,815)
(737,236)
(106,877)
General and administrative expenses
(64,883)
(80,326)
(11,645)
Research and development expenses
(22,637)
(39,440)
(5,718)
Total operating expenses
(693,178)
(918,140)
(133,103)
Loss from operations
(34,051)
(98,951)
(14,345)
Financial income
10,606
10,741
1,557
Foreign currency exchange gain (loss)
10,664
(3,198)
(464)
Income from equity method investments, net
2,505
12,389
1,796
Other income, net
4,242
18,466
2,677
Loss before income tax expenses
(6,034)
(60,553)
(8,779)
Income tax benefits (expenses)
433
(1,375)
(199)
Net loss
(5,601)
(61,928)
(8,978)
Net loss attributable to non-controlling interests and redeemable non-
controlling interests
298
1,414
205
Net loss attributable to Yatsen's shareholders
(5,303)
(60,514)
(8,773)
Shares used in calculating loss per share (1):
Weighted average number of Class A and Class B ordinary shares:
Basic
1,837,466,068
1,876,901,662
1,876,901,662
Diluted
1,837,466,068
1,876,901,662
1,876,901,662
Net loss per Class A and Class B ordinary share
Basic
(0.00)
(0.03)
(0.00)
Diluted
(0.00)
(0.03)
(0.00)
Net loss per ADS (20 ordinary shares equal to 1 ADS) (2)
Basic
(0.06)
(0.64)
(0.09)
Diluted
(0.06)
(0.64)
(0.09)
For the Three Months Ended March 31,
2025
2026
2026
Share-based compensation expenses are included in the
operating expenses as follows:
RMB'000
RMB'000
USD'000
Fulfilment expenses
98
249
36
Selling and marketing expenses
757
148
21
General and administrative expenses
7,731
2,003
290
Research and development expenses
40
1,159
168
Total
8,626
3,559
515
(1) Authorized share capital is re-classified and re-designated into Class A ordinary shares and Class B ordinary shares, with each
Class A ordinary share being entitled to one vote and each Class B ordinary share being entitled to twenty votes on all matters that
are subject to shareholder vote.
YATSEN HOLDING LIMITED
UNAUDITED RECONCILIATIONS OF GAAP AND NON-GAAP RESULTS
(All amounts in thousands, except for share, per share data or otherwise noted)
For the Three Months Ended March 31,
2025
2026
2026
RMB'000
RMB'000
USD'000
Loss from operations
(34,051)
(98,951)
(14,345)
Share-based compensation expenses
8,626
3,559
515
Amortization of intangible assets resulting from assets and business
acquisitions
10,561
10,759
1,560
Non-GAAP loss from operations
(14,864)
(84,633)
(12,270)
Net loss
(5,601)
(61,928)
(8,978)
Share-based compensation expenses
8,626
3,559
515
Amortization of intangible assets resulting from assets and business
acquisitions
10,561
10,759
1,560
Revaluation of investments on the share of equity method
investments
(6,010)
(10,469)
(1,518)
Tax effects on non-GAAP adjustments
(433)
829
120
Non-GAAP net income (loss)
7,143
(57,250)
(8,301)
Net loss attributable to Yatsen's shareholders
(5,303)
(60,514)
(8,773)
Share-based compensation expenses
8,626
3,559
515
Amortization of intangible assets resulting from assets and business
acquisitions
10,179
10,473
1,518
Revaluation of investments on the share of equity method
investments
(6,010)
(10,469)
(1,518)
Tax effects on non-GAAP adjustments
(405)
829
120
Non-GAAP net income (loss) attributable to Yatsen's
shareholders
7,087
(56,122)
(8,138)
Shares used in calculating loss per share:
Weighted average number of Class A and Class B ordinary shares:
Basic
1,837,466,068
1,876,901,662
1,876,901,662
Diluted
1,953,491,427
1,876,901,662
1,876,901,662
Non-GAAP net income (loss) attributable to ordinary
shareholders per Class A and Class B ordinary share
Basic
0.00
(0.03)
(0.00)
Diluted
0.00
(0.03)
(0.00)
Non-GAAP net income (loss) attributable to ordinary
shareholders per ADS (20 ordinary shares equal to 1 ADS) (1)
Basic
0.08
(0.60)
(0.09)
Diluted
0.07
(0.60)
(0.09)
View original content:https://www.prnewswire.com/news-releases/yatsen-announces-first-quarter-2026-financial-results-302781575.html